100+ Free Singapore Patent Agents QE Paper D Practice Questions

Pass your Singapore Patent Agents Qualifying Examination Paper D - Patent Law & Practice exam on the first try — instant access, no signup required.

✓ No registration✓ No credit card✓ No hidden fees✓ Start practicing immediately

22-25% Pass Rate

100+ Questions

100% Free

Loading practice questions...

2026 Statistics

Key Facts: Singapore Patent Agents QE Paper D Exam

4 hours

Exam Time Limit

IPOS

50%

Passing Mark

IPOS QE Rules

Open-Book

Exam Format

IPOS guidelines

SGD 642

Standard Exam Fee

IPOS 2026

Cap 221

Patents Act Chapter

Singapore Statutes

22-25%

Historical Pass Rate

Professional Statistics

The Singapore Patent Agents QE Paper D is a 4-hour open-book exam administered by IPOS with a passing score of 50%. It tests the practical application of Singapore patent law, covering the Patents Act (Cap 221), Patents Rules, and IPOS Examination Guidelines. Key topics include patentability requirements, patent prosecution and procedures, infringement analysis, validity and revocation challenges, pre- and post-grant amendments, PCT national phase entry, and patent agent ethics. It is a highly challenging professional qualification with a historical pass rate of around 22-25%.

Sample Singapore Patent Agents QE Paper D Practice Questions

Try these sample questions to test your Singapore Patent Agents QE Paper D exam readiness. Each question includes a detailed explanation. Start the interactive quiz above for the full 100+ question experience with AI tutoring.

1Under Section 14(2) of the Singapore Patents Act (Cap 221), which of the following is considered part of the 'state of the art' for the purpose of assessing the novelty of an invention?

A.Any matter made available to the public in Singapore or elsewhere by written or oral description, by use, or in any other way before the priority date.

B.Only written descriptions published in registered patent journals in Singapore before the filing date.

C.Any oral disclosure made anywhere in the world, provided it was recorded and published in writing before the priority date.

D.Only matter that was publicly used or known within the territory of Singapore before the priority date.

Explanation: Section 14(2) of the Singapore Patents Act defines the state of the art as comprising all matter (whether a product, a process, information about either, or anything else) which has at any time before the priority date of the invention been made available to the public (whether in Singapore or elsewhere) by written or oral description, by use or in any other way. This establishes an absolute global novelty standard that includes oral descriptions and public use worldwide, not just in Singapore.

2In Singapore, can a pending but unpublished Singapore patent application with an earlier priority date be used to challenge the novelty and inventive step of a subsequent patent application?

A.It can be used to challenge the novelty of the subsequent application under Section 14(3), but it is disregarded for the purpose of assessing inventive step under Section 15.

B.It can be used to challenge both the novelty under Section 14(3) and the inventive step under Section 15 of the subsequent application.

C.It cannot be used for either novelty or inventive step because it was not published at the priority date of the subsequent application.

D.It can only be used if the applicant of the subsequent application had actual knowledge of the earlier unpublished application.

Explanation: Under Section 14(3) of the Singapore Patents Act, the state of the art for novelty includes matter contained in another patent application which was published on or after the priority date of the subsequent application, if its filing/priority date is earlier. However, Section 15 explicitly states that such Section 14(3) applications are disregarded when determining whether an invention involves an inventive step, preventing the combining of unpublished applications to argue obviousness.

3Under the Patents Act, if an inventor discloses their invention publicly on 1 June 2025 and subsequently files a Singapore patent application on 1 March 2026, how is this prior disclosure treated during examination?

A.It is excluded from the state of the art under Section 14(4) because it was disclosed by the inventor within the 12-month grace period before the filing date.

B.It destroys the novelty of the application because Singapore does not provide a grace period for voluntary disclosures by the inventor.

C.It is only excluded from the state of the art if the disclosure was made in breach of a confidentiality agreement by a third party.

D.It is excluded from the state of the art only if the applicant files a petition and pays a penalty fee for late filing.

Explanation: Following the 2017 amendments to the Singapore Patents Act, Section 14(4)(e) provides a broad 12-month grace period for disclosures made by the inventor, or by a person who obtained the information directly or indirectly from the inventor. Since the disclosure on 1 June 2025 occurred within the 12 months preceding the filing date of 1 March 2026, it is excluded from the state of the art when assessing novelty and inventive step.

4Which of the following claim formulations is NOT deemed capable of industrial application under Section 16(2) of the Singapore Patents Act?

A.A method of diagnosing diabetes mellitus practiced directly on the human body.

B.A diagnostic kit containing test strips and reagents for detecting blood glucose levels.

C.A process for manufacturing a pharmaceutical compound for treating diabetes.

D.A surgical scalpel coated with an antimicrobial polymer.

Explanation: Section 16(2) of the Patents Act explicitly states that an invention of a method of treatment of the human or animal body by surgery or therapy or of diagnosis practiced on the human or animal body shall not be deemed capable of industrial application. Thus, a diagnostic method practiced directly on the body is excluded. However, Section 16(3) clarifies that this exclusion does not apply to products (such as diagnostic kits, pharmaceutical compounds, or surgical tools) used in any such method.

5How are 'second medical use' claims for known substances or compositions evaluated and drafted under current IPOS practice?

A.Both Swiss-type claims ('Use of X in the manufacture of a medicament...') and EPC 2000 claims ('X for use in the treatment of...') are accepted and recognized as novel and industrially applicable.

B.Only Swiss-type claims are accepted; EPC 2000 claims are rejected as lacking industrial applicability under Section 16(2).

C.Only EPC 2000 claims are accepted; Swiss-type claims are rejected as being directed to an unpatentable method of manufacture.

D.Second medical use claims are completely prohibited in Singapore as they are deemed to lack novelty over the first medical use.

Explanation: Under IPOS Examination Guidelines, Singapore recognizes the patentability of second medical uses of known substances. IPOS accepts both Swiss-type formats ('Use of substance X in the manufacture of a medicament for the treatment of disease Y') and EPC 2000 formats ('Substance X for use in the treatment of disease Y') as formats that overcome the method of medical treatment exclusion and carry novelty derived from the new therapeutic indication.

6For a diagnostic method to be excluded from patentability in Singapore as not being capable of industrial application, what condition must be met under IPOS Guidelines?

A.The method must include all the steps necessary to make a diagnostic decision, and all steps of a technical nature must be practiced directly on the living human or animal body.

B.The method only needs to involve the analysis of an in vitro sample (e.g., blood) previously extracted from the body.

C.The method must be performed exclusively by a registered medical practitioner in a Singapore hospital.

D.The method must involve the use of an imaging machine such as an MRI or X-ray scanner.

Explanation: Under IPOS Patent Examination Guidelines, a method of diagnosis is only excluded under Section 16(2) if it is practiced directly on the human or animal body. If the method is performed on a sample that has been removed from the body (in vitro), it is not considered practiced on the body and is therefore patentable. Additionally, for the exclusion to apply, the method must cover all steps required to reach a diagnostic decision.

7An inventor's assistant accidentally discloses the details of a new engine to a supplier in breach of a signed non-disclosure agreement (NDA) on 10 January 2025. What is the deadline for the inventor to file a patent application in Singapore to prevent this disclosure from destroying novelty?

A.9 January 2026, which is 12 months from the date of the unauthorized disclosure.

B.10 July 2025, which is 6 months from the date of the unauthorized disclosure.

C.There is no deadline because disclosures in breach of confidence are permanently excluded from the state of the art.

D.The application must be filed immediately on the same day the breach is discovered.

Explanation: Under Section 14(4)(a) of the Singapore Patents Act, a disclosure of an invention is disregarded if it was made in breach of confidence (e.g., breach of an NDA), provided that the patent application is filed within 12 months of the disclosure. Therefore, the inventor must file the application on or before 9 January 2026 (within the 12-month grace period) to protect the invention's novelty.

8What is the requirement for a computer-implemented invention (software) to be patentable in Singapore under IPOS Guidelines?

A.It must solve a technical problem or produce a technical effect that goes beyond the normal physical interactions between the software and the hardware.

B.All computer programs are patentable in Singapore, as Singapore does not exclude computer programs from patentability.

C.Software is only patentable if it is coupled with a novel hardware device that has been manufactured in Singapore.

D.Computer programs are explicitly excluded from patentability in Singapore under Section 13, similar to the European Patent Convention.

Explanation: Singapore does not have a statutory exclusion for computer programs as such. However, to be patentable, an invention must have a technical character. IPOS Guidelines state that a computer-implemented invention is patentable if it provides a technical contribution—meaning it solves a technical problem or produces a technical effect beyond the routine physical interactions of software running on a computer.

9Under Section 13(2) of the Patents Act, which category of inventions is excluded from patentability on the grounds of public interest or morality?

A.Inventions the publication or exploitation of which would be generally expected to encourage offensive, immoral or antisocial behavior.

B.Inventions that compete directly with state-owned enterprises or Singapore statutory boards.

C.Inventions that do not generate commercial revenue within three years of grant.

D.Inventions in the field of defense or military technology that are kept secret.

Explanation: Section 13(2) of the Singapore Patents Act states that an invention is not a patentable invention if the publication or exploitation of it would be generally expected to encourage offensive, immoral or antisocial behavior. (Section 13(1) sets out the three positive conditions of patentability: novelty, inventive step and industrial applicability.) Section 13(2) is the statutory ground for excluding inventions on moral or public order grounds.

10In the context of assessing novelty, does a 'selection patent' that selects a narrow sub-range of chemical concentrations from a previously disclosed broad range meet the novelty requirement in Singapore?

A.Yes, provided the selected sub-range is narrow, is not specifically disclosed in the prior art, and exhibits a new technical effect or advantage not generic to the wider range.

B.No, because any disclosure of a broad range automatically anticipates every individual value and sub-range within that range.

C.Yes, but only if the prior art document explicitly stated that the selected sub-range should be patented separately.

D.No, selection patents are prohibited in Singapore under the IPOS Guidelines to prevent double patenting.

Explanation: Singapore law recognizes selection patents. For a selected sub-range to be novel, it must be narrow compared to the broad range, must not have been specifically disclosed (e.g., as a worked example), and the selection must be purposive—meaning the selected range must exhibit a new advantage or characteristic that is not possessed by the rest of the broad range.

About the Singapore Patent Agents QE Paper D Exam

The Singapore Patent Agents Qualifying Examination Paper D (Patent Law & Practice) is a comprehensive open-book written exam designed to assess a candidate's knowledge of Singapore patent law and its practical application. The exam covers key aspects of the Singapore Patents Act (Cap 221), Patents Rules, and IPOS Guidelines, including patentability criteria, filing and prosecution procedures, priority claims, search and examination reports, divisional applications, patent infringement, validity, revocation, pre- and post-grant amendments, international treaties (PCT, Budapest, ASPEC), and professional conduct/ethics. Candidates must apply these legal concepts to practical scenarios faced by patent agents in Singapore.

Assessment

Written open-book essay format featuring 3-5 multi-part scenario-based questions.

Time Limit

4 hours

Passing Score

50%

Exam Fee

SGD 642 (Intellectual Property Office of Singapore (IPOS))

Singapore Patent Agents QE Paper D Exam Content Outline

20%

Patentability Requirements & Exclusions

Assess novelty (Section 14), inventive step (Section 15), industrial applicability (Section 16), and exceptions/exclusions under Section 13 (methods of medical treatment, biological processes, computer programs).

25%

Patent Prosecution & IPOS Procedure

Advise on filing, specifications, priority claims under Section 17, search/examination pathways, divisional applications, extension of time, and restoration of lapsed patents.

20%

Patent Infringement Analysis & Defenses

Determine infringing acts under Section 66, apply principles of claim construction (purposive vs. literal construction), assess statutory exceptions to infringement (private/non-commercial use, research, prior use), and advise on remedies and groundless threats.

15%

Patent Validity, Revocation & Amendments

Evaluate grounds for revocation under Section 80, prosecute pre-grant and post-grant patent amendments under Sections 38 and 83, and address double patenting.

12%

International Treaties & PCT Application

Advise on PCT national phase entry under Sections 85 and 86, Paris Convention, Budapest Treaty, and utilize PPH/ASPEC programs.

Patent Agency Practice & Professional Ethics

Understand patent agent registration requirements, comply with the Rules of Conduct, manage conflicts of interest, and apply professional privilege under Section 104.

How to Pass the Singapore Patent Agents QE Paper D Exam

What You Need to Know

Passing score: 50%
Assessment: Written open-book essay format featuring 3-5 multi-part scenario-based questions.
Time limit: 4 hours
Exam fee: SGD 642

Keys to Passing

Complete 500+ practice questions
Score 80%+ consistently before scheduling
Focus on highest-weighted sections
Use our AI tutor for tough concepts

Singapore Patent Agents QE Paper D Study Tips from Top Performers

1Familiarize yourself with the layout and index of the Patents Act (Cap 221) and Rules so you can quickly find relevant sections during the open-book exam.

2Always provide specific statutory citations (e.g., Section 13 for patentability, Section 66 for infringement) to support your legal reasoning.

3Understand the search and examination pathways in Singapore (e.g., local search and exam, mixed routes, and foreign-aligned routes) and their respective deadlines.

4Practice drafting legal advice on patent infringement, specifically applying purposive construction to the claims and evaluating defenses like private non-commercial use.

5Review the grounds for revocation (Section 80) and be clear on the difference between pre-grant amendments (Section 38) and post-grant amendments (Section 83).

6Be clear on the timeline and requirements for PCT national phase entry in Singapore under Section 85/86, including late entry provisions.

7Study the Patents (Patent Agents) Rules, particularly the code of conduct, conflicts of interest, and professional privilege under Section 104.

Frequently Asked Questions

What is covered in Paper D of the Singapore Patent Agents QE?

Paper D covers the substantive patent law and patent practice guidelines of Singapore. This includes a deep understanding of the Singapore Patents Act (Cap 221), Patents Rules, and IPOS Examination Guidelines. It requires candidates to solve practical scenarios involving patentability, prosecution, infringement, validity, revocation, amendments, international treaties, and ethics.

Is the Singapore Patent Agents QE Paper D exam open-book?

Yes, Paper D is an open-book exam. Candidates are permitted to bring physical copies of legal texts, including the Patents Act, Patents Rules, examination guidelines, and personal study notes or textbooks into the examination hall.

What is the passing score for Paper D?

The passing score for Paper D (as with all other QE papers) is 50% or higher. Scoring is based on a candidate's ability to identify legal issues, cite the relevant Sections or Rules of the Patents Act/Rules, and apply the law to the facts presented.

How long is the Paper D exam?

The Paper D exam is a 4-hour written exam. Because it requires reading complex factual scenarios and drafting structured legal opinions or advice, time management is critical.

What are the registration fees for the patent agents exam in Singapore?

The registration fee for first to third attempts (Tier 1) is SGD 642 per paper (inclusive of GST). Subsequent attempts (fourth and beyond, Tier 2) are charged at a higher fee. There is also a non-refundable enrolment fee of SGD 32.10.

What are the prerequisites to register as a patent agent in Singapore?

To register as a patent agent, you must have a university degree or equivalent, pass all four papers of the QE (or hold relevant exemptions), and complete at least 12 months of supervised practical experience in patent agency work in Singapore under a registered patent agent.